Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand
Description
CONCLUSIONS: ChAdOx1 vaccine may provide superior immunogenicity than CoronaVac and natural infection.
